CTOs on the Move

Keune Haircosmetics

www.keune.com

 
Keune Haircosmetics is a Lawrenceville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.keune.com
  • 1440 Lakes Pkwy Ste 500
    Lawrenceville, GA USA 30043
  • Phone: 678.377.5226

Executives

Name Title Contact Details

Similar Companies

Echo Solution

Echo, a HealthStream Company, is a combination of two industry leading software development companies, HealthLine Systems and Sy.Med Development. Echo develops and supports a comprehensive solution set for healthcare provider credentialing, privileging, enrollment, referral, onboarding, and analytics. Echo is supported by an industry leading development and client services staff with significant combined experience in the healthcare industry.

Protab Laboratories

Protab Laboratories is a Rancho Santa Margarita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

USA Managed Care Organization

USA Managed Care Organization (USA MCO) is the largest, most comprehensive, privately-held healthcare corporation in America

College Health Enterprises

College Health Enterprises is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.